Another element to take into account is the clinical variability and stratification of phenotypes to which steroid treatment is leading DMD patients — as to date, the vast majority of clinical trials require steroid treatment as an inclusion criterion in order to standardize patients’ recruitment — characterized by intermediate DMD-BMD clinical pictures along with variable cardiac involvement, differently affecting motor performance. Here, DMD is linked to Duchenne muscular dystrophy.